Johann Bauersachs

Johann Bauersachs's AcademicInfluence.com Rankings

Johann Bauersachs

Physics

#3529

World Rank

#4989

Historical Rank

physics Degrees

Download Badge

Physics

Why Is Johann Bauersachs Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Prof. Dr. Johann Bauersachs is a German internist, cardiologist, and full professor at the Hannover Medical School. He is widely recognized for his scholarly contributions to the domains of acute coronary syndrome, left ventricular repair and remodelling following ischemia, and acute and chronic heart failure.

(See a Problem?)

Johann Bauersachs's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2013) (6036)
2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous (2014) (3302)
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts (2008) (2253)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. (2020) (2041)
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. (2015) (1708)
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. (2018) (1035)
2021 ESC/EACTS Guidelines for the management of valvular heart disease. (2021) (993)
MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure (2007) (954)
The 2013 ESH/ESC guidelines for the management of arterial hypertension (2013) (805)
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy (2012) (493)
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology (2019) (469)
Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. (1996) (461)
Cardiac Angiogenic Imbalance Leads to Peri-partum Cardiomyopathy (2012) (451)
Characterization of endothelium‐derived hyperpolarizing factor as a cytochrome P450‐derived arachidonic acid metabolite in mammals. (1994) (441)
Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology (2018) (436)
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology (2018) (402)
MicroRNA-24 Regulates Vascularity After Myocardial Infarction (2011) (394)
Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. (2011) (393)
Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial (2018) (388)
Endothelial Nitric Oxide Synthase Uncoupling Impairs Endothelial Progenitor Cell Mobilization and Function in Diabetes (2007) (385)
Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. (1999) (369)
MicroRNAs: novel regulators in cardiac development and disease. (2008) (363)
Activation of CD4+ T Lymphocytes Improves Wound Healing and Survival After Experimental Myocardial Infarction in Mice (2012) (360)
Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. (1997) (319)
Mechanisms of Disease: Toll-like receptors in cardiovascular disease (2007) (309)
Post-infarct remodelling: contribution of wound healing and inflammation (2008) (290)
Age-Dependent Impairment of Endothelial Progenitor Cells Is Corrected by Growth Hormone Mediated Increase of Insulin-Like Growth Factor-1 (2007) (290)
Complementary and Incremental Mortality Risk Prediction by Cortisol and Aldosterone in Chronic Heart Failure (2007) (280)
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy (2013) (279)
Ca2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. (1998) (278)
Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair (2011) (275)
Improvement of Left Ventricular Remodeling and Function by Hydroxymethylglutaryl Coenzyme A Reductase Inhibition With Cerivastatin in Rats With Heart Failure After Myocardial Infarction (2001) (261)
Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. (2005) (245)
A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction (2013) (240)
Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2017) (231)
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study (2017) (229)
Effect of YC‐1, an NO‐independent, superoxide‐sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators (1997) (227)
Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis. (2008) (225)
Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension (2008) (223)
Peripartum cardiomyopathy: current management and future perspectives (2015) (214)
Deletion of Cardiomyocyte Mineralocorticoid Receptor Ameliorates Adverse Remodeling After Myocardial Infarction (2011) (203)
A transferable, beta‐naphthoflavone‐inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells. (1996) (194)
Display of the characteristics of endothelium‐derived hyperpolarizing factor by a cytochrome P450‐derived arachidonic acid metabolite in the coronary microcirculation (1994) (193)
Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology (2018) (191)
The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. (2005) (186)
Short Communication: Asymmetric Dimethylarginine Impairs Angiogenic Progenitor Cell Function in Patients With Coronary Artery Disease Through a MicroRNA-21–Dependent Mechanism (2010) (185)
Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction (2008) (183)
Catheter-Based Renal Nerve Ablation and Centrally Generated Sympathetic Activity in Difficult-to-Control Hypertensive Patients: Prospective Case Series (2012) (181)
Gut Microbiota–Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes (2018) (179)
Endothelial dysfunction in heart failure. (2008) (174)
2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). (2022) (173)
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology (2019) (172)
Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction. (2003) (172)
Cannulation strategies for percutaneous extracorporeal membrane oxygenation in adults (2015) (172)
The continuous heart failure spectrum: moving beyond an ejection fraction classification. (2019) (170)
Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production. (1998) (170)
Biogenesis and Regulation of Cardiovascular MicroRNAs (2011) (169)
Myocardial Inflammation Predicts Remodeling and Neuroinflammation After Myocardial Infarction. (2018) (165)
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy (2019) (165)
Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy (2016) (165)
Long-Term Prognosis of Patients With Takotsubo Syndrome. (2018) (164)
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. (2012) (163)
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine (2020) (159)
Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction. (2015) (159)
Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression. (2002) (158)
Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure. (2003) (156)
Chemokine Fractalkine Mediates Leukocyte Recruitment to Inflammatory Endothelial Cells in Flowing Whole Blood: A Critical Role for P-Selectin Expressed on Activated Platelets (2007) (156)
Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology (2018) (155)
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. (2001) (155)
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology (2019) (155)
Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology (2020) (155)
Calcium-dependent and calcium-independent activation of the endothelial NO synthase. (1997) (154)
Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction (2013) (154)
Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis. (2008) (152)
MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart (2012) (151)
Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction (2015) (144)
Happy heart syndrome: role of positive emotional stress in takotsubo syndrome (2016) (142)
Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease (2018) (140)
Mineralocorticoid Receptor Activation and Mineralocorticoid Receptor Antagonist Treatment in Cardiac and Renal Diseases (2015) (139)
Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion. (2004) (139)
Rapid Regulation of Platelet Activation In Vivo by Nitric Oxide (2003) (138)
Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure (2016) (137)
Immediate Mineralocorticoid Receptor Blockade Improves Myocardial Infarct Healing by Modulation of the Inflammatory Response (2008) (135)
Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial. (2018) (134)
Attenuation of Angiotensin II–Induced Vascular Dysfunction and Hypertension by Overexpression of Thioredoxin 2 (2009) (134)
Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM) (2017) (134)
Immune mechanisms in heart failure (2017) (133)
A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry (2017) (132)
Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function—value of the wearable cardioverter/defibrillator (2014) (130)
Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction. (2015) (130)
Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. (2008) (128)
Ablation of Mineralocorticoid Receptors in Myocytes But Not in Fibroblasts Preserves Cardiac Function (2011) (125)
2021 ESC/EACTS Guidelines for the management of valvular heart disease. (2021) (124)
Absence of NF‐κB subunit p50 improves heart failure after myocardial infarction (2006) (124)
Isometric contraction induces the Ca2+-independent activation of the endothelial nitric oxide synthase. (1999) (123)
Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury (2014) (122)
Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells. (2006) (121)
Comparison of different miR-21 inhibitor chemistries in a cardiac disease model. (2011) (120)
Small animal models of heart failure (2019) (117)
Of mice and men: models and mechanisms of diabetic cardiomyopathy (2018) (115)
European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure (2019) (114)
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study (2020) (114)
Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (2016) (113)
Improvement in Left Ventricular Remodeling by the Endothelial Nitric Oxide Synthase Enhancer AVE9488 After Experimental Myocardial Infarction (2008) (113)
Novel therapeutic approaches to post-infarction remodelling. (2012) (108)
Self‐care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology (2020) (108)
Apoptosis Repressor With Caspase Recruitment Domain Is Required for Cardioprotection in Response to Biomechanical and Ischemic Stress (2006) (105)
Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin. (2002) (103)
A Role for Caspase-1 in Heart Failure (2007) (103)
Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy (2016) (102)
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology (2021) (102)
The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC (2018) (101)
The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology (2017) (100)
ECMO in cardiac arrest and cardiogenic shock (2017) (99)
Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research. (2016) (96)
Reverse Epidemiology in Systolic and Nonsystolic Heart Failure: Cumulative Prognostic Benefit of Classical Cardiovascular Risk Factors (2009) (96)
Inflammatory Monocytes Determine Endothelial Nitric-oxide Synthase Uncoupling and Nitro-oxidative Stress Induced by Angiotensin II* (2014) (96)
Letter by Thum et al regarding article, "Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone". (2008) (95)
Targeting myocardial remodelling to develop novel therapies for heart failure (2014) (94)
Heart failure drug treatment: the fantastic four (2021) (93)
Inhibition of inducible nitric oxide synthase restores endothelium-dependent relaxations in proinflammatory mediator-induced blood vessels. (1997) (91)
Regulation of monocyte cell fate by blood vessels mediated by Notch signalling (2016) (91)
Treatments targeting inotropy. (2018) (91)
The Differential Diagnosis of Dyspnea. (2016) (90)
Improvement of Endothelial Dysfunction by Selective Estrogen Receptor-&agr; Stimulation in Ovariectomized SHR (2003) (88)
Long‐term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy (2018) (87)
Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy (2017) (85)
Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology (2020) (85)
Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) (84)
Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy. (2015) (84)
Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial (2017) (84)
Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative: evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease. (2007) (83)
Mineralocorticoid Receptor Blockade Improves Vasomotor Dysfunction and Vascular Oxidative Stress Early After Myocardial Infarction (2007) (82)
Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction. (2006) (81)
An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology (2018) (81)
Circulating cardiovascular microRNAs in critically ill COVID‐19 patients (2021) (80)
Characterizing the Inflammatory Tissue Response to Acute Myocardial Infarction by Clinical Multimodality Noninvasive Imaging (2014) (79)
Emerging translational approaches to target STAT3 signalling and its impact on vascular disease (2015) (78)
Recommendations for extracorporeal cardiopulmonary resuscitation (eCPR): consensus statement of DGIIN, DGK, DGTHG, DGfK, DGNI, DGAI, DIVI and GRC (2018) (78)
The transcription factor GATA4 promotes myocardial regeneration in neonatal mice (2017) (76)
Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats. (2008) (75)
Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling. (2002) (75)
Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study (2017) (73)
Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the α‐glucosidase inhibitor acarbose (2005) (73)
C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure (2017) (72)
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care (2020) (72)
Regulation of Myocardial Fibrosis by MicroRNAs (2010) (72)
Mental disorders in adults with congenital heart disease: Unmet needs and impact on quality of life. (2016) (71)
Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: An independent predictor of mortality (2008) (71)
Reduced Vascular NO Bioavailability in Diabetes Increases Platelet Activation In Vivo (2004) (71)
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. (2019) (70)
Peroxisome proliferator activated‐receptor agonism and left ventricular remodeling in mice with chronic myocardial infarction (2004) (70)
Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension (2016) (70)
Heart Failure Association of the European Society of Cardiology update on sodium–glucose co‐transporter 2 inhibitors in heart failure (2020) (69)
C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function (2019) (68)
Mitochondrial Thioredoxin Reductase Is Essential for Early Postischemic Myocardial Protection (2011) (67)
Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury. (2007) (67)
Improvement of vascular function by acute and chronic treatment with the PDE‐5 inhibitor sildenafil in experimental diabetes mellitus (2008) (67)
Endothelial dysfunction in heart failure: mechanisms and therapeutic approaches. (2004) (67)
Inhibition of platelet activation in congestive heart failure by aldosterone receptor antagonism and ACE inhibition (2003) (66)
Blood vessel control of macrophage maturation promotes arteriogenesis in ischemia (2017) (66)
Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction. (2003) (66)
Rosuvastatin Reduces Platelet Activation in Heart Failure: Role of NO Bioavailability (2005) (64)
Impact of COVID-19 outbreak on regional STEMI care in Germany (2020) (64)
Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis (2017) (64)
Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I. (2007) (64)
Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease. (2022) (63)
Eligibility for Renal Denervation: Experience at 11 European Expert Centers (2014) (63)
Low circulating androgens and mortality risk in heart failure (2009) (63)
Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry (2019) (61)
Fractalkine Is Expressed in Early and Advanced Atherosclerotic Lesions and Supports Monocyte Recruitment via CX3CR1 (2012) (61)
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2020) (61)
Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction. (2005) (61)
Reverse Epidemiology in Systolic and Nonsystolic Heart FailureCLINICAL PERSPECTIVE (2009) (60)
Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study (2015) (60)
Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans (2010) (59)
CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction (2003) (59)
The cannabinoid receptor‐1 antagonist rimonabant inhibits platelet activation and reduces pro‐inflammatory chemokines and leukocytes in Zucker rats (2008) (59)
Antiandrogenic Therapy With Finasteride Attenuates Cardiac Hypertrophy and Left Ventricular Dysfunction (2015) (59)
Key inflammatory mechanisms underlying heart failure (2019) (58)
Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. (2009) (58)
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry. (2020) (57)
Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [68Ga]pentixafor PET/CT (2018) (57)
Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy (2015) (56)
Activation of CD 4 T Lymphocytes Improves Wound Healing and Survival After Experimental Myocardial Infarction in Mice (2012) (56)
Striking Increase of Natriuresis by Low-Dose Spironolactone in Congestive Heart Failure Only in Combination With ACE Inhibition: Mechanistic Evidence to Support RALES (2000) (56)
Left ventricular remodeling after myocardial infarction in mice with targeted deletion of the NADPH oxidase subunit gp91PHOX (2006) (55)
Towards a re‐definition of ‘cardiac hypertrophy’ through a rational characterization of left ventricular phenotypes: a position paper of the Working Group ‘Myocardial Function’ of the ESC (2011) (55)
Circulating miR-423_5p fails as a biomarker for systemic ventricular function in adults after atrial repair for transposition of the great arteries. (2013) (55)
Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome. (2019) (54)
Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo Registry (2019) (53)
Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology (2020) (53)
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2020) (53)
Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study. (2002) (52)
Early Escalation of Mechanical Circulatory Support Stabilizes and Potentially Rescues Patients in Refractory Cardiogenic Shock (2020) (51)
Vascular endothelial dysfunction and superoxide anion production in heart failure are p38 MAP kinase-dependent. (2004) (51)
Clinical hemodynamic evaluation of patients implanted with a fully magnetically levitated left ventricular assist device (HeartMate 3). (2017) (51)
Endothelium-dependent and -independent relaxation and VASP serines 157/239 phosphorylation by cyclic nucleotide-elevating vasodilators in rat aorta. (2003) (50)
Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure (2017) (50)
Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated Patients with Chronic Obstructive Pulmonary Disease (CLAIM). A Double‐Blind, Randomized, Crossover Trial (2019) (48)
Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition (2014) (48)
Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy. (2002) (47)
N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. (2007) (46)
Acute coronary syndrome or Takotsubo cardiomyopathy: The suspect may not always be the culprit. (2015) (46)
The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury (2009) (45)
Prevention of endothelial dysfunction in heart failure by vitamin E: attenuation of vascular superoxide anion formation and increase in soluble guanylyl cyclase expression. (2001) (45)
HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo‐controlled pilot study (2007) (45)
Evidence of autoantibodies against cardiac troponin I and sarcomeric myosin in peripartum cardiomyopathy (2015) (45)
Aerobic training in adults after atrial switch procedure for transposition of the great arteries improves exercise capacity without impairing systemic right ventricular function. (2013) (44)
Caught in the act: in vivo molecular imaging of the transcription factor NF-kappaB after myocardial infarction. (2006) (44)
Digoxin–mortality: randomized vs. observational comparison in the DIG trial (2019) (43)
Endothelin-receptor blockade improves endothelial vasomotor dysfunction in heart failure. (2000) (43)
Differential Effects of Organic Nitrates on Endothelial Progenitor Cells Are Determined by Oxidative Stress (2007) (43)
Tetrahydrobiopterin and eNOS dimer/monomer ratio--a clue to eNOS uncoupling in diabetes? (2005) (43)
Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement. (2015) (43)
Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4. (2020) (42)
Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study (2019) (42)
Extrinsic Notch Ligand Delta-Like 1 Regulates Tip Cell Selection and Vascular Branching Morphogenesis (2012) (42)
Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study (2019) (42)
The new INNOVANCE® PFA P2Y cartridge is sensitive to the detection of the P2Y12 receptor inhibition (2011) (42)
Sonic hedgehog-dependent activation of adventitial fibroblasts promotes neointima formation (2017) (41)
Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism (2004) (41)
Haeme oxygenase promotes progenitor cell mobilization, neovascularization, and functional recovery after critical hindlimb ischaemia in mice. (2008) (41)
Innate immunity and the heart. (2005) (41)
Simultaneous dual-isotope solid-state detector SPECT for improved tracking of white blood cells in suspected endocarditis (2016) (41)
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high‐risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology (2020) (40)
Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK) (2021) (40)
Coexistence and outcome of coronary artery disease in Takotsubo syndrome. (2020) (40)
MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease (2016) (39)
Role of 5-lipoxygenase in myocardial ischemia-reperfusion injury in mice. (2007) (39)
Inhibition of cyclic AMP- and cyclic GMP-mediated dilations in isolated arteries by oxidized low density lipoproteins. (1992) (39)
Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy (2019) (39)
The struggle towards a Universal Definition of Heart Failure-how to proceed? (2021) (39)
Long‐term follow‐up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co‐morbidities (2019) (38)
Modulation of platelet and monocyte function by the chemokine fractalkine (CX3CL1) in cardiovascular disease (2015) (38)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. (2021) (38)
Toll-like receptor signaling in the ischemic heart. (2008) (38)
Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice. (2009) (38)
Exercise training improves vascular mitochondrial function. (2016) (36)
Heart against veno-arterial ECMO: Competition visualized. (2015) (36)
Cytochrome P450 2C expression and EDHF-mediated relaxation in porcine coronary arteries is increased by cortisol. (2002) (36)
First series of left ventricular assist device exchanges to HeartMate 3 (2017) (36)
The CX3C Chemokine Fractalkine Induces Vascular Dysfunction by Generation of Superoxide Anions (2007) (36)
Guanylyl cyclase activator ataciguat improves vascular function and reduces platelet activation in heart failure. (2010) (35)
Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy (2020) (35)
Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease. (2012) (35)
Improvement of biological age by physical activity. (2014) (35)
2021 ESC/EACTS Guidelines for the management of valvular heart disease. (2021) (35)
ν-net: Deep Learning for Generalized Biventricular Mass and Function Parameters Using Multicenter Cardiac MRI Data. (2018) (35)
Inactivation of Sox9 in fibroblasts reduces cardiac fibrosis and inflammation. (2019) (33)
ADP-induced platelet aggregation frequently fails to detect impaired clopidogrel-responsiveness in patients with coronary artery disease compared to a P2Y12-specific assay (2008) (33)
Pharmacological pre‐ and post‐conditioning with the sphingosine‐1‐phosphate receptor modulator FTY720 after myocardial ischaemia–reperfusion (2010) (33)
One‐year outcomes with the HeartMate 3 left ventricular assist device (2018) (33)
Differential effects of organic nitrates on endothelial progenitor cells are determined by oxidative stress. (2007) (33)
Mortality in patients with cardiogenic shock treated with the Impella CP microaxial pump for isolated left ventricular failure (2020) (33)
CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction. (2003) (33)
Eplerenone improves vascular function and reduces platelet activation in diabetic rats. (2010) (32)
Early ivabradine treatment in patients with acute peripartum cardiomyopathy: Subanalysis of the German PPCM registry. (2016) (32)
The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury (2017) (32)
Highly Specific Detection of Myostatin Prodomain by an Immunoradiometric Sandwich Assay in Serum of Healthy Individuals and Patients (2013) (32)
Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study (2017) (32)
Ca -Independent Activation of the Endothelial Nitric Oxide Synthase in Response to Tyrosine Phosphatase Inhibitors and Fluid Shear Stress (1998) (31)
Paracrine functions of the coronary vascular endothelium (1996) (31)
Age-Related Variations in Takotsubo Syndrome. (2020) (31)
Acquired von Willebrand syndrome in cardiogenic shock patients on mechanical circulatory microaxial pump support (2017) (30)
Mitochondrial long noncoding RNAs as blood based biomarkers for cardiac remodeling in patients with hypertrophic cardiomyopathy. (2016) (30)
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC) (2021) (30)
5-Lipoxygenase facilitates healing after myocardial infarction (2013) (30)
Macrophage Mineralocorticoid Receptor Is a Pleiotropic Modulator of Myocardial Infarct Healing (2018) (29)
Current Drug Therapy in Chronic Heart Failure: the New Guidelines of the European Society of Cardiology (ESC) (2017) (29)
Diagnostic accuracy of cadmium-zinc-telluride-based myocardial perfusion SPECT: impact of attenuation correction using a co-registered external computed tomography. (2016) (29)
Targeting of Extracellular RNA Reduces Edema Formation and Infarct Size and Improves Survival After Myocardial Infarction in Mice (2017) (28)
Mortality in Patients With Out-of-Hospital Cardiac Arrest Undergoing a Standardized Protocol Including Therapeutic Hypothermia and Routine Coronary Angiography: Experience From the HACORE Registry. (2018) (28)
Hydralazine prevents endothelial dysfunction, but not the increase in superoxide production in nitric oxide-deficient hypertension. (1998) (28)
Simvastatin improves left ventricular function after myocardial infarction in hypercholesterolemic rabbits by anti-inflammatory effects. (2006) (28)
First series of mechanical circulatory support in non-compaction cardiomyopathy: Is LVAD implantation a safe alternative? (2015) (27)
Diagnostic evaluation of the hospital depression scale (HADS) and the Beck depression inventory II (BDI-II) in adults with congenital heart disease using a structured clinical interview: Impact of depression severity (2020) (27)
Angiopoietin-2 in Adults with Congenital Heart Disease and Heart Failure (2013) (27)
Nitric oxide and endothelium-derived hyperpolarizing factor: formation and interactions. (1997) (27)
Increased Cancer Prevalence in Peripartum Cardiomyopathy (2019) (27)
The glucocorticoid receptor in monocyte-derived macrophages is critical for cardiac infarct repair and remodeling (2017) (27)
Medroxyprogesterone Acetate But Not Drospirenone Ablates the Protective Function of 17β-Estradiol in Aldosterone Salt-Treated Rats (2006) (27)
Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome: Insights From the International Takotsubo Registry. (2019) (27)
Asymmetrical Dimethylarginine - More Sensitive than NT-proBNP to Diagnose Heart Failure in Adults with Congenital Heart Disease (2012) (26)
MiRNA‐181a is a novel regulator of aldosterone–mineralocorticoid receptor‐mediated cardiac remodelling (2020) (26)
Acquired right coronary artery fistula draining to the right ventricle: angiographic documentation of first appearance following reperfusion after acute myocardial infarction, with subsequent spontaneous closure (2003) (26)
Interaction of the heart and its close and distant neighbours: report of the Meeting of the ESC Working Groups Myocardial Function and Cellular Biology. (2013) (26)
Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy (2021) (25)
Prognostic value of NT-proBNP in patients with systemic morphological right ventricles: a single-centre experience. (2013) (25)
The ARTS of third-generation mineralocorticoid receptor antagonists: achieving cardiovascular benefit with minimized renal side effects? (2013) (25)
[Cardiovascular disease in pregnancy]. (2016) (25)
Endothelial NO synthase target of aldosterone. (2006) (25)
Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction (2018) (25)
The Treatment of Heart Failure with Reduced Ejection Fraction. (2020) (25)
Kommentar zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Behandlung der akuten und chronischen Herzinsuffizienz (2013) (24)
Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances (2012) (24)
Circulating concentrations of fibroblast activation protein α in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA. (2013) (24)
MicroRNAs in the broken heart (2007) (24)
The role of l-arginine/l-homoarginine/nitric oxide pathway for aortic distensibility and intima-media thickness in stroke patients (2017) (24)
Increased platelet activation in young Zucker rats with impaired glucose tolerance is improved by acarbose (2004) (24)
Molecular Imaging of Chemokine Receptor CXCR4 in Non-Small Cell Lung Cancer Using 68Ga-Pentixafor PET/CT: Comparison With 18F-FDG. (2016) (23)
Blunted Cortisol Stress Response and Depression-Induced Hypocortisolism Is Related to Inflammation in Patients With CAD. (2016) (23)
Clopidogrel improves endothelial function and NO bioavailability by sensitizing adenylyl cyclase in rats with congestive heart failure (2011) (23)
The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine (2020) (23)
The prognostic significance of the 12-lead ECG in peripartum cardiomyopathy. (2019) (23)
Cardiac iron concentration in relation to systemic iron status and disease severity in non‐ischaemic heart failure with reduced ejection fraction (2020) (22)
EMC10 (Endoplasmic Reticulum Membrane Protein Complex Subunit 10) Is a Bone Marrow–Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction (2017) (22)
Moderate and severe periodontitis are independent risk factors associated with low cardiorespiratory fitness in sedentary non-smoking men aged between 45 and 65 years. (2014) (22)
Soluble Guanylyl Cyclase Activation With HMR1766 Attenuates Platelet Activation in Diabetic Rats (2006) (22)
Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus. (2007) (22)
A novel open‐source software‐based high‐precision workflow for target definition in cardiac radioablation (2020) (21)
Improvement of renal dysfunction in rats with chronic heart failure after myocardial infarction by treatment with the endothelin A receptor antagonist, LU 135252 (2000) (21)
Fibroblast GATA-4 and GATA-6 promote myocardial adaptation to pressure overload by enhancing cardiac angiogenesis (2021) (21)
Induction of cardiomyocyte proliferation and angiogenesis protects neonatal mice from pressure overload-associated maladaptation. (2019) (21)
Takotsubo syndrome: between evidence, myths, and misunderstandings (2020) (21)
Assessment of myocardial function using MRI-based feature tracking in adults after atrial repair of transposition of the great arteries: Reference values and clinical utility. (2016) (21)
Impact of aspirin on takotsubo syndrome: a propensity score‐based analysis of the InterTAK Registry (2019) (21)
Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus. (2007) (21)
Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury (2014) (20)
The direct factor Xa inhibitor Rivaroxaban reduces platelet activation in congestive heart failure. (2013) (20)
Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy (2017) (20)
Dilated cardiomyopathies and non-compaction cardiomyopathy (2020) (20)
IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction—a retrospective propensity score analysis (2020) (20)
Blood-based microRNA profiling in patients with cardiac amyloidosis (2018) (20)
Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation (2015) (20)
Increased Cytochrome P4502E1 Expression and Altered Hydroxyeicosatetraenoic Acid Formation Mediate Diabetic Vascular Dysfunction (2010) (19)
Inhibition of platelet activation in rats with severe congestive heart failure by a novel endothelial nitric oxide synthase transcription enhancer (2009) (19)
Clinical Predictors and Prognostic Impact of Recovery of Wall Motion Abnormalities in Takotsubo Syndrome: Results From the International Takotsubo Registry (2019) (19)
MAP-Kinase Activated Protein Kinase 2 Links Endothelial Activation and Monocyte/macrophage Recruitment in Arteriogenesis (2015) (19)
Inflammatory Drivers of Cardiovascular Disease: Molecular Characterization of Senescent Coronary Vascular Smooth Muscle Cells (2020) (18)
Initial experience with telemonitoring in left ventricular assist device patients. (2019) (18)
First-in-Man Fully Percutaneous Complete Bypass of Heart and Lung. (2017) (18)
Molecular Imaging Identifies Fibroblast Activation Beyond the Infarct Region After Acute Myocardial Infarction. (2021) (18)
Endothelium-derived hyperpolarizing factor, but not nitric oxide, is reversibly inhibited by brefeldin A. (1997) (18)
Oral iron supplementation with ferric maltol in patients with pulmonary hypertension (2020) (18)
The year in cardiovascular medicine 2020: heart failure and cardiomyopathies. (2021) (18)
Mineralocorticoid receptor antagonism and cardiac remodeling in ischemic heart failure. (2004) (18)
Late thrombosis of a drug-eluting stent during combined anti-platelet therapy in a clopidogrel nonresponsive diabetic patient: Shall we routinely test platelet function ? (2007) (18)
The chemokine receptor CX 3 CR1 coordinates monocyte recruitment and endothelial regeneration after arterial injury (2017) (18)
$ν$-net: Deep Learning for Generalized Biventricular Cardiac Mass and Function Parameters (2017) (18)
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients (2020) (18)
Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure (2020) (18)
Role of p38 mitogen‐activated protein kinase in cardiac remodelling (2007) (17)
High dose aspirin and left ventricular remodeling after myocardial infarction (2007) (17)
Efficacy of mineralocorticoid receptor antagonism in the acute myocardial infarction phase: eplerenone versus spironolactone (2015) (17)
Early determination of clopidogrel responsiveness by platelet reactivity index identifies patients at risk for cardiovascular events after myocardial infarction (2011) (17)
Endothelial progenitor cell dysfunction: mechanisms and therapeutic approaches (2007) (17)
Tyrosine Phosphatase Inhibitors and Fluid Shear Stress-Independent Activation of the Endothelial Nitric Oxide Synthase in Response to 2 + Ca (1998) (17)
In peripartum cardiomyopathy Plasminogen Activator Inhibitor-1 is a potential new biomarker with controversial roles. (2019) (17)
Endothelial progenitor cells as potential drug targets. (2005) (16)
Diagnostik und Therapie der kardialen Amyloidose (2019) (16)
miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation (2020) (16)
Endothelin receptor antagonists in heart failure: current status and future directions. (2004) (16)
Platelet activation in heart failure. (2004) (16)
Haemodynamic simulation and the effect of early left ventricular unloading in pre‐shock acute coronary syndrome (2019) (16)
Angiographic detection of fatal acute aortic dissection Stanford type A under resuscitation. (2016) (16)
Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers (2020) (16)
miR-21: a central regulator of fibrosis not only in the broken heart. (2012) (16)
Guía de práctica clínica de la ESC sobre revascularización miocárdica, 2014 (2015) (16)
Mineralocorticoid receptor antagonists for therapy of coronary artery disease and related complications. (2013) (16)
Factor VII‐activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation (2016) (15)
Molecular imaging of inflammation crosstalk along the cardio-renal axis following acute myocardial infarction (2021) (15)
Peripartum cardiomyopathy (2018) (15)
Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome (2022) (15)
NT-proBNP Indicates Left Ventricular Impairment and Adverse Clinical Outcome in Patients with Tetralogy of Fallot and Pulmonary Regurgitation (2016) (15)
Drug treatment of heart failure in the elderly (2018) (15)
Detrimental effects of testosterone on post-myocardial infarction remodelling in female rats. (2007) (15)
Heparan Sulfate-Editing Extracellular Sulfatases Enhance Vascular Endothelial Growth Factor Bioavailability for Ischemic Heart Repair. (2019) (15)
Organic nitrates differentially modulate circulating endothelial progenitor cells and endothelial function in patients with symptomatic coronary artery disease. (2011) (14)
Septal total atrial conduction time for prediction of atrial fibrillation in embolic stroke of unknown source: a pilot study (2019) (14)
Peripartum cardiomyopathy: from genetics to management. (2021) (14)
Effect of chronic heart failure on nuclear factor kappa B in peripheral leukocytes. (2004) (14)
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. (2021) (14)
Poor Outcomes in Poor Patients?: Peripartum Cardiomyopathy-Not Just Black and White. (2017) (14)
Fractalkine promotes platelet activation and vascular dysfunction in congestive heart failure (2013) (14)
Systemic application of sirolimus prevents neointima formation not via a direct anti-proliferative effect but via its anti-inflammatory properties. (2017) (14)
Empfehlungen zur extrakorporalen kardiopulmonalen Reanimation (eCPR) (2018) (14)
Mechanical circulatory support for takotsubo syndrome: a systematic review and meta-analysis. (2020) (14)
ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models (2014) (14)
Prediction of short‐ and long‐term mortality in takotsubo syndrome: the InterTAK Prognostic Score (2019) (14)
Timely and individualized heart failure management: need for implementation into the new guidelines (2021) (14)
Skeletal muscle derived Musclin protects the heart during pathological overload (2022) (14)
Electric smog: telemetry interference between ICD and LVAD (2017) (14)
Changes in concentrations of circulating fibroblast activation protein alpha are associated with myocardial damage in patients with acute ST-elevation MI. (2017) (14)
Pentaerythritol Tetranitrate Targeting Myocardial Reactive Oxygen Species Production Improves Left Ventricular Remodeling and Function in Rats With Ischemic Heart Failure (2015) (13)
Microarray-based gene expression profiling to elucidate cellular responses to nitric oxide--a review from an analytical and biomedical point of view. (2007) (13)
Aldosterone antagonism in heart failure: improvement of cardiac remodelling, endothelial dysfunction and platelet activation (2004) (13)
Intermediate CD14++CD16+ monocytes decline after transcatheter aortic valve replacement and correlate with functional capacity and left ventricular systolic function (2017) (13)
Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence. (2020) (13)
Meteorin-like promotes heart repair through endothelial KIT receptor tyrosine kinase (2022) (13)
Contemporary Management of Severe Symptomatic Aortic Stenosis. (2021) (13)
Mineralocorticoid receptor in cardiovascular diseases—Clinical trials and mechanistic insights (2021) (13)
Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts (2003) (13)
Impact of different bone marrow cell preparations on left ventricular remodelling after experimental myocardial infarction (2008) (13)
Coronary artery treatment with an urea-based paclitaxel-coated balloon: The European wide Falcon all comers DCB Registry (FALCON-Registry). (2019) (13)
Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure. (2003) (13)
The Three-Decade Long Journey in Heart Failure Drug Development. (2017) (13)
Reductive stress: linking heat shock protein 27, glutathione, and cardiomyopathy? (2010) (12)
Furosemide induces mortality in a rat model of chronic heart failure. (2012) (12)
The Nitric Oxide Donor Pentaerythritol Tetranitrate Reduces Platelet Activation in Congestive Heart Failure (2015) (12)
Fractalkine Activates a Signal Transduction Pathway Similar to P2Y12 and Is Associated With Impaired Clopidogrel Responsiveness (2012) (12)
Spike rate of multi-unit muscle sympathetic nerve fibers after catheter-based renal nerve ablation. (2015) (12)
TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation (2019) (12)
A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload (2018) (12)
Immunity and inflammation: the neglected key players in congenital heart disease? (2021) (12)
Assessment of major mental disorders in a German peripartum cardiomyopathy cohort (2020) (12)
A collagen α2(I) mutation impairs healing after experimental myocardial infarction. (2012) (12)
Somatic Development in Children with Congenital Heart Defects (2018) (12)
Extracorporeal membrane oxygenation and surgical embolectomy for high-risk pulmonary embolism (2019) (12)
Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction (2016) (12)
Reduced basal nitric oxide bioavailability and platelet activation in young spontaneously hypertensive rats. (2004) (11)
Impact of Atrial Fibrillation on Outcome in Takotsubo Syndrome: Data From the International Takotsubo Registry (2021) (11)
Extracorporeal membrane oxygenation for severe ARDS due to immune diffuse alveolar hemorrhage: a retrospective observational study. (2019) (11)
Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice. (2018) (11)
Cardiomyocyte mineralocorticoid receptor function post myocardial infarction. (2011) (11)
Bromocriptine for the Treatment of Peripartum Cardiomyopathy. (2018) (11)
Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series (2022) (11)
Diverging Trends in Age at First Myocardial Infarction: Evidence from Two German Population-Based Studies (2020) (11)
Angiotensin-Converting Enzyme Inhibition and Endothelin Antagonism for Endothelial Dysfunction in Heart Failure: Mono-or Combination Therapy (2002) (11)
High-altitude pulmonary edema: potential protection by red wine. (2002) (11)
[Recommendations for extracorporeal cardiopulmonary resuscitation (eCPR) : Consensus statement of DGIIN, DGK, DGTHG, DGfK, DGNI, DGAI, DIVI and GRC]. (2018) (10)
Growth hormone regulates vascular function—what we know from bench and bedside (2006) (10)
CXCR4-Targeted Imaging of Post-Infarct Myocardial Tissue Inflammation: Prognostic Value After Reperfused Myocardial Infarction. (2021) (10)
Retinal myeloid cells regulate tip cell selection and vascular branching morphogenesis via Notch ligand Delta-like 1 (2019) (10)
Expansion of CD10neg neutrophils and CD14+HLA-DRneg/low monocytes driving proinflammatory responses in patients with acute myocardial infarction (2021) (10)
Therapeutic modulation of RNA-binding protein Rbm38 facilitates re-endothelialization after arterial injury (2019) (10)
Echocardiography and biomarkers for the diagnosis of cardiotoxicity (2020) (10)
Soluble neprilysin, NT-proBNP, and growth differentiation factor-15 as biomarkers for heart failure in dialysis patients (SONGBIRD) (2020) (10)
Five-year outcomes of patients supported with HeartMate 3: a single-centre experience. (2021) (10)
Extracorporeal Hemoadsorption: An Option for COVID-19 Associated Cytokine Storm Syndrome (2020) (10)
Neuromarkers and neurological outcome in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia–experience from the HAnnover COoling REgistry (HACORE) (2021) (10)
[2021 ESC/EACTS Guidelines for the management of valvular heart disease]. (2022) (10)
Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca2+-ATPase Expression in Cardiomyocytes (2021) (10)
New drugs: big changes in conservative heart failure therapy? (2019) (10)
Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice (2016) (10)
[Update of the ESC guidelines 2018 on cardiovascular diseases during pregnancy : Most important facts]. (2018) (9)
Multidrug resistance associated protein-1 (MRP1) deficiency attenuates endothelial dysfunction in diabetes. (2016) (9)
The year in cardiovascular medicine 2021: heart failure and cardiomyopathies (2021) (9)
A mechanistic model for atherosclerosis and its application to the cohort of Mayak workers (2017) (9)
Evidence for the use of mineralocorticoid receptor antagonists in the treatment of coronary artery disease and post-angioplasty restenosis. (2017) (9)
Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy: results from the ESC EORP PPCM registry (2021) (9)
More NO-no more ROS: combined selective mineralocorticoid receptor blockade and angiotensin-converting enzyme inhibition for vascular protection. (2008) (9)
[Recommendations for extracorporeal cardiopulmonary resuscitation (eCPR) : Consensus statement of DGIIN, DGK, DGTHG, DGfK, DGNI, DGAI, DIVI and GRC]. (2018) (9)
Curriculum Kardiologie (2020) (9)
PET Imaging of Cardiac Wound Healing Using a Novel [68Ga]-Labeled NGR Probe in Rat Myocardial Infarction (2015) (9)
Curriculum Herzinsuffizienz (2018) (9)
P6168Digitoxin serum concentrations affecting patient safety and potential outcome in patients with HFrEF - analyses of the ongoing DIGIT-HF-trial (2017) (8)
Kurzversion der 2. Auflage der deutsch-österreichischen S3-Leitlinie „Infarkt-bedingter Kardiogener Schock – Diagnose, Monitoring und Therapie“ (2020) (8)
Extended follow‐up after wearable cardioverter‐defibrillator period: the PROLONG‐II study (2021) (8)
BET bromodomain containing epigenetic reader proteins regulate vascular smooth muscle cell proliferation and neointima formation. (2020) (8)
Therapeutic targets of ataciguat (2007) (8)
Empfehlungen zur extrakorporalen kardiopulmonalen Reanimation (eCPR) (2018) (8)
Use of extracorporeal membrane oxygenation for eCPR in the emergency room in patients with refractory out-of-hospital cardiac arrest (2020) (8)
Anti-Thrombotic Strategies in Elderly Patients Receiving Platelet Inhibitors. (2019) (8)
Inhibition of proteasome‐mediated glucocorticoid receptor degradation restores nitric oxide bioavailability in myocardial endothelial cells in vitro (2014) (8)
Echocardiographic Changes in Patients Implanted With a Fully Magnetically Levitated Left Ventricular Assist Device (Heartmate 3). (2019) (8)
Mineralocorticoid receptor activation and antagonism in cardiovascular disease: cellular and molecular mechanisms. (2022) (8)
Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta‐analysis of randomized controlled trials (2022) (8)
Lateral Thoracotomy for Ventricular Assist Device Implantation: A Meta-Analysis of Literature (2021) (8)
Pathologic endothelial response and impaired function of circulating angiogenic cells in patients with Fabry disease (2012) (8)
N-Terminal ProB-Type Natriuretic Peptide Predicts Total and Cardiovascular Mortality in Individuals with or without Stable Coronary Artery Disease : The Ludwigshafen Risk and Cardiovascular Health Study (2007) (8)
Therapeutic Plasma Exchange Decreases Levels of Routinely Used Cardiac and Inflammatory Biomarkers (2012) (8)
Effects of personalized endurance training on cellular age and vascular function in middle-aged sedentary women (2019) (8)
Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity (2018) (8)
Targeting the aldosterone pathway in cardiovascular disease (2012) (8)
The H(2)-receptor antagonist ranitidine interferes with clopidogrel-mediated P2Y(12) inhibition in platelets. (2010) (8)
Endothelium-dependent and -independent vasoreactivity of rat basilar artery in chronic heart failure. (2000) (7)
Spotlight on endothelial progenitor cell inhibitors: short review (2005) (7)
Pathophysiology of Chronic Venous Insufficiency (1996) (7)
Therapeutic Hypothermia following Cardiac Arrest after the TTM2 trial - more Questions Raised than Answered. (2021) (7)
ADMA, endothelial progenitor cells, and cardiovascular risk. (2005) (7)
Prevalence of Child Maltreatment in Adults With Congenital Heart Disease and Its Relationship With Psychological Well-Being, Health Behavior, and Current Cardiac Function (2021) (7)
MicroRNAs in cardiac hypertrophy and failure (2008) (7)
Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative (2017) (7)
Prediction of heart failure and death in an adult population of Fontan patients (2019) (7)
Current drug therapy for heart failure with reduced ejection fraction (2018) (7)
Early use of hemoadsorption in patients after out-of hospital cardiac arrest – a matched pair analysis (2020) (7)
The novel P2Y 12 antagonist AZD6140 rapidly and reversibly reduces platelet activation in diabetic rats. (2010) (7)
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI (2020) (7)
Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry (2021) (7)
[Short version of the 2nd edition of the German-Austrian S3 guidelines "Cardiogenic shock complicating myocardial infarction-Diagnosis, monitoring and treatment"]. (2020) (7)
Takotsubo cardiomyopathy: Completely simple but not so easy. (2015) (7)
Blood-based protein profiling identifies serum protein c-KIT as a novel biomarker for hypertrophic cardiomyopathy (2021) (7)
Pathophysiology and risk factors of peripartum cardiomyopathy (2022) (7)
Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology. (2021) (7)
Genetic ablation of fibroblast activation protein alpha attenuates left ventricular dilation after myocardial infarction (2021) (7)
Spotlight on endothelial progenitor cell inhibitors: short review (2005) (7)
Role of the sGC activator ataciguat sodium (HMR1766) in cardiovascular disease (2007) (7)
Mechanical circulatory support in refractory cardiogenic shock due to influenza virus-related myocarditis (2020) (6)
Novel Strategies in Anti-Platelet Treatment for Coronary Artery Disease (2009) (6)
Erratum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease. (2022) (6)
Tetrahydrobiopterin, endothelial nitric oxide synthase, and mitochondrial function in the heart. (2009) (6)
Plasma Concentrations of Myeloid-Derived Growth Factor in Healthy Individuals and Patients with Acute Myocardial Infarction as Assessed by Multiple Reaction Monitoring-Mass Spectrometry. (2018) (6)
Evaluation of Myocardial Gene Expression Profiling for Superior Diagnosis of Idiopathic Giant-Cell Myocarditis and Clinical Feasibility in a Large Cohort of Patients with Acute Cardiac Decompensation (2020) (6)
Aminoethyl nitrate – the novel super nitrate? (2009) (6)
Abstract 12476: Increased Cytochrome P4502E1 Expression and Altered Hydroxyeicosatetraenoic Acid Formation Mediate Diabetic Vascular Dysfunction: Rescue by Guanylyl-Cyclase Activation (2010) (6)
Impaired platelet responses to clopidogrel and ticlopidine in a patient with recurrent coronary stent stenosis (2004) (6)
Kurzversion der 2. Auflage der deutsch-österreichischen S3-Leitlinie „Infarkt-bedingter Kardiogener Schock – Diagnose, Monitoring und Therapie“ (2020) (6)
Onkologische Kardiologie (2020) (6)
Anti-androgenic therapy with finasteride in patients with chronic heart failure - a retrospective propensity score based analysis (2019) (6)
Cleaved high-molecular-weight kininogen inhibits neointima formation following vascular injury (2015) (6)
Triple Cannulation ECMO (2016) (6)
Depression Associated with Reduced Heart Rate Variability Predicts Outcome in Adult Congenital Heart Disease (2021) (6)
Modeling Cardiac Fibrosis in Mice: (Myo)Fibroblast Phenotype After Ischemia. (2017) (6)
Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry (2021) (6)
[Focused update on dual antiplatelet treatment : ESC guidelines 2017]. (2017) (6)
Increased epicardial adipose tissue in young adults with congenital heart disease comorbid with major depressive disorder. (2019) (6)
Heart rate control in heart failure with reduced ejection fraction: the bright and the dark side of the moon (2020) (5)
Devil in Disguise: Hints and Pitfalls in Diagnosis of Peripartum Cardiomyopathy. (2018) (5)
Sunday, 26 August 2012 (2012) (5)
Trauma induced by nontraumatic coronary devices and its impact on vascular reactivity and morphology. (2002) (5)
Growth hormone treatment improves markers of systemic nitric oxide bioavailability via the insulin-like growth factor-1 Importance for endothelial progenitor cells. (2007) (5)
Clinical correlates and prognostic impact of neurologic disorders in Takotsubo syndrome (2021) (5)
Hospitalizations for heart failure: still major differences between East and West Germany 30 years after reunification (2021) (5)
Underestimated risk for life-threatening ventricular arrhythmias in newly diagnosed peripartum cardiomyopathy? (2015) (5)
Artificial Intelligence Identifies an Urgent Need for Peripheral Vascular Intervention by Multiplexing Standard Clinical Parameters (2021) (5)
Factors That Influence Adherence to Medication in Adults With Congenital Heart Disease (ACHD) (2021) (5)
Genetic reporter analysis reveals an expandable reservoir of OCT4+ cells in adult skin (2014) (5)
Kommentar zu den Leitlinien (2019) der ESC zum chronischen Koronarsyndrom (2020) (5)
S ustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure (2003) (5)
Empfehlungen zur extrakorporalen kardiopulmonalen Reanimation (eCPR) (2018) (5)
Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy. (2016) (5)
Severe neutropenia under clopidogrel treatment three weeks after coronary stenting (2007) (5)
Kommentar zu den Leitlinien 2017 der Europäischen Gesellschaft für Kardiologie (ESC) zur Therapie des akuten Herzinfarktes bei Patienten mit ST-Streckenhebung (2018) (5)
Prevalence of Obstructive Coronary Artery Disease in Ambulatory Patients with Stable Angina Pectoris (2015) (5)
Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO‐DKD trial (2022) (5)
Extracorporeal membrane oxygenation for acute respiratory distress syndrome due to Pneumocystis pneumonia (2019) (5)
microRNA-206 correlates with left ventricular function after transcatheter aortic valve implantation. (2017) (5)
Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla® Flex II Occluder (2016) (5)
Mineralocorticoid Receptor-Dependent Adverse Remodeling After Myocardial Infarction Mediated by uNGALant Activation of NFκB. (2017) (4)
Guía ESC 2018 sobre el tratamiento de las enfermedades cardiovasculares durante el embarazo (2019) (4)
Sports or statins for atheroprotection? New insight from Kruppel-like factor 2. (2006) (4)
INFLAMMATION AND VASCULAR REMODELING IN COVID-19 HEARTS (2022) (4)
The European Society of Cardiology Heart Failure Association Study Group on Peripartum Cardiomyopathy – what has been achieved in 10 years (2020) (4)
Cardiac regeneration by progenitor cells – bedside before bench? (2005) (4)
Standardized secondary prevention in patients with ST-elevation myocardial infarction. (2020) (4)
Left heart function in COPD (2019) (4)
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care. (2021) (4)
Cumulative Prognostic Benefit of Classical Cardiovascular Risk Factors (2009) (4)
Arterial size determines the enhancement of contractile responses after suppression of endothelium-derived relaxing factor formation (1993) (4)
Impella mechanical circulatory support for Takotsubo syndrome with shock: A retrospective multicenter analysis. (2021) (4)
Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy. (2017) (4)
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction (2021) (4)
Indacaterol/Glycopyrronium improves pulmonary ventilation and ventilation inhomogeneity in the CLAIM Study (2018) (4)
Sodium-Glukose-Transporter 2(SGLT2)-Hemmer bei Herzinsuffizienz (2022) (4)
Erratum: Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair (Proceedings of the National Academy of Sciences (2011) 108, 33 (13438-13443) DOI: 10.1073/ pnas.1016546108) (2012) (4)
Toll-like receptors: emerging therapeutic targets for heart failure (2010) (4)
Aufbau und Organisation von Herzinsuffizienz-Netzwerken (HF-NETs) und Herzinsuffizienz-Einheiten (Heart Failure Units [HFUs]) zur Optimierung der Behandlung der akuten und chronischen Herzinsuffizienz – Update 2021 (2022) (4)
Giant cell myocarditis after first dose of BNT162b2 – a case report (2022) (4)
Linksventrikuläres Unloading im kardiogenen Schock (2016) (4)
Characterization of peripartum cardiomyopathy by cardiovascular magnetic resonance imaging (2015) (4)
[New pharmacologic therapies for chronic heart failure]. (2017) (4)
Unloading in Refractory Cardiogenic Shock After Out-Of-Hospital Cardiac Arrest Due to Acute Myocardial Infarction—A Propensity Score-Matched Analysis (2021) (4)
Heart failure, platelet activation and inhibition of the renin-angiotensin-aldosterone system. (2004) (3)
Abstract 182: CTRP9 - A Novel Cardiac Derived Secreted Factor With Anti-hypertrophic Properties (2013) (3)
Endothelin Receptor Antagonists in Heart Failure (2012) (3)
[Therapy of aortic valve stenosis]. (2014) (3)
Scientific updates on the interaction of genes, epigenetics, and multicellularity in cardiovascular diseases: the Working Group of Myocardial Function of the ESC. (2018) (3)
Myocardial infarction in grown up patients with congenital heart disease: An emerging high-risk combination. (2016) (3)
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function: simply effects of optimized drug treatment? (2005) (3)
Novel therapeutic strategies to reduce reperfusion injury after acute myocardial infarction. (2022) (3)
Herzinsuffizienzleitlinien 2021 der ESC (2021) (3)
Das Brugada-Syndrom (2012) (3)
Clopidogrel – klinischer Einsatz und mögliche Therapieprobleme (2008) (3)
Kommentar zu den 2020er Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zum Management des akuten Koronarsyndroms bei Patienten ohne persistierende ST-Strecken-Hebung (2021) (3)
Optimized Implementation of cardiac resynchronization therapy – a call for action for referral and optimization of care (2021) (3)
Maintenance Immunosuppression Is Associated With Better Outcome in the 2017/2018 Influenza Epidemic (2019) (3)
Effects of six month personalized endurance training on work ability in middle-aged sedentary women: a secondary analysis of a randomized controlled trial (2020) (3)
Prognostic impact of acute pulmonary triggers in patients with takotsubo syndrome: new insights from the International Takotsubo Registry (2021) (3)
[Guidelines of the ESC 2021 on heart failure]. (2021) (3)
Treatments targeting inotropy A position paper of the Committees on Translational Research and Acute Heart Failure of the Heart Failure Association of the European Society of Cardiology (2019) (3)
Two's company: double-chambered right ventricle[corrected]. (2013) (3)
Echocardiographic Parameters to Predict Atrial Fibrillation in Clinical Routine—The EAHsy-AF Risk Score (2022) (3)
Symmetrical dimethylarginine is superior to NT-proBNP for detecting systemic ventricular dysfunction in adults after atrial repair for transposition of the great arteries. (2013) (3)
Current and future use of neuromodulation in heart failure (2022) (3)
Role of activators of ferric sGC in cardiovascular disease (2005) (3)
Localizing the air vents: functional imaging-guided diagnosis in extensive multilocal subcutaneous emphysema. (2013) (3)
Abstract 219: Cardiac Angiogenic Imbalance Leads to Peripartum Cardiomyopathy (2012) (3)
Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter–Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction (2021) (3)
Positionspapier Nuklearkardiologie – Update 2018 (2018) (3)
Clinical care for patients with recurrent myocardial ischemia in Germany-the VOICES trial. (2018) (3)
Targeting pulmonary hypertension in patients with heart failure and preserved ejection fraction: rather static than DYNAMIC development? (2022) (2)
Kommentar zu den Leitlinien (2021) der ESC zur Diagnose und Behandlung akuter und chronischer Herzinsuffizienz (2022) (2)
Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy (2019) (2)
Single coronary artery anomaly with interarterial left main: caught inbetween. (2015) (2)
Abstract 19359: Inhibition of miR-146a Attenuates Neointima Formation (2016) (2)
Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST (2021) (2)
Kommentar zu den Leitlinien (2018) der ESC zum Management von kardiovaskulären Erkrankungen in der Schwangerschaft (2019) (2)
Safe Exchange of a Transfemoral Impella Pump. (2019) (2)
Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy (2021) (2)
Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials (2022) (2)
Cardiooncology—dealing with modern drug treatment, long-term complications, and cancer survivorship (2021) (2)
Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology—A PROLONG-II Substudy (2022) (2)
[Aldosterone receptor blockade after acute myocardial infarction with heart failure]. (2006) (2)
Pregnancy-associated cardiomyopathies (2014) (2)
Reply to 'Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a nationwide Danish cohort'. (2018) (2)
Therapie der Aortenklappenstenose (2014) (2)
Standardisierte Kontrastmittelsonographie (CEUS) in der klinischen Akut- und Notfallmedizin sowie Intensivmedizin (CEUS Akut) (2022) (2)
Analysis of myocardial cellular gene expression during pressure overload reveals matrix based functional intercellular communication (2022) (2)
[Obesity and heart failure]. (2008) (2)
Qualification, knowledge, tasks and responsibilities of the clinical perfusionist in Germany. (2020) (2)
Abstract 18267: Ivabradine in Acute Heart Failure: A Therapeutic Means for Effective Heart Rate Control (2015) (2)
[Care of patients with chronic heart failure: an interdisciplinary challenge]. (2021) (2)
Kommentar zur 2014-ESC-Leitlinie zum Management der akuten Lungenembolie (2015) (2)
Empfehlungen zur extrakorporalen kardiopulmonalen Reanimation (eCPR) (2018) (2)
Cardiopulmonary interaction in heart or lung disease: physiology, disturbances, and their clinical implications (2019) (2)
Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir (2021) (2)
Dynamic obstruction of the left main coronary artery ostium by a papillary fibroelastoma. (2014) (2)
First-in-Man Use of the Percutaneous 10F Reitan Catheter Pump for Cardiorenal Syndrome. (2021) (2)
ECG and arrhythmias in peripartum cardiomyopathy (2021) (2)
Management of patients with heart failure and secondary mitral regurgitation (2020) (2)
Guía ESC/EACTS 2021 sobre el diagnóstico y tratamiento de las valvulopatías (2022) (2)
Impact of fasting on stress systems and depressive symptoms in patients with major depressive disorder: a cross-sectional study (2022) (2)
673 Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure (2007) (2)
Improvement of Left Ventricular Ejection Fraction by a Novel Electrical Microcurrent Therapy in a Sheep Model of Chronic Heart Failure (2019) (2)
Multimodal Elimination for Intoxication with a Lethal Dose of Organic Mercury (2019) (2)
Circulating microRNAs in Symptomatic and Asymptomatic Carotid Stenosis (2021) (2)
Symmetrical dimethylarginine is superior to NT-proBNP for detecting systemic ventricular dysfunction in adults after atrial repair for transposition of the great arteries (2013) (2)
[Policy paper nuclear cardiology - update 2018 - Current status of clinical practice]. (2018) (2)
Dynamic left ventricular outflow tract obstruction: Hemodynamic pitfall ahead (2013) (2)
Abstract 3706: NO Independent Activation of Soluble Guanylyl Cyclase Provides Additional Benefit to ACE Inhibition on Cardiac Remodeling Postinfarction (2009) (2)
Advanced preconditioning: Impella 5.5 support for decompensated heart failure before left ventricular assist device surgery. (2020) (2)
RISK SCORES AND BIOMARKERS FOR THE PREDICTION OF 1-YEAR OUTCOME AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2015) (2)
Pre-clinical data on involvement of mineralocorticoid receptor activation in healing and remodelling post-myocardial infarction (2011) (2)
P2Y12 inhibition in acute coronary syndromes treated with percutaneous intervention - Understanding the debate on Prasugrel or Ticagrelor. (2021) (2)
[Clopidogrel--clinical use and potential therapeutic problems]. (2008) (2)
The transcription factor GATA4 promotes myocardial regeneration in neonatal mice (2019) (2)
[The wearable cardioverter/defibrillator : Temporary protection from sudden cardiac death]. (2016) (2)
[Platelet inhibition in elderly patients]. (2018) (1)
Cardiogenic shock due to a spontaneously ruptured pheochromocytoma: a rare but life-threatening event—a case report (2022) (1)
Enhancer AVE9488 After Experimental Myocardial Infarction Improvement in Left Ventricular Remodeling by the Endothelial Nitric Oxide Synthase (2008) (1)
P3395Early dual mechanical support in refractory cardiogenic shock is a promising therapeutic strategy (2017) (1)
[Ventricular arrhythmias : What has been confirmed in therapy?] (2017) (1)
EFFICACY OF PRASUGREL IN RESUSCITATED PATIENTS DURING THERAPEUTIC HYPOTHERMIA AFTER PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE MYOCARDIAL INFARCTION (2014) (1)
Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies (2022) (1)
Response to catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to- control hypertensive patients. (2013) (1)
TCT-22 Dual Mechanical Support Combining Impella Microaxial Pump and Veno-arterial ECMO Rescues High-risk Patients in Refractory Cardiogenic Shock. (2016) (1)
Endothelial Cell GATA2 Modulates the Cardiomyocyte Stress Response through the Regulation of Two Long Non-Coding RNAs (2022) (1)
Abstract 3752: Mineralocorticoid Receptor Antagonism Prevents Aldosterone Mediated Dysfunction of Human Endothelial Progenitor Cells in Vitro, in Vivo and in Patients (2008) (1)
Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the Week. (2023) (1)
Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9): Impact of PCSK9 on Major Adverse Cardiac and Cerebrovascular Events. (2017) (1)
Additive Impact of Interleukin 6 and Neuron Specific Enolase for Prognosis in Patients With Out-of-Hospital Cardiac Arrest – Experience From the HAnnover COoling REgistry (2022) (1)
High prevalence of reduced fertility and use of assisted reproductive technology in a German cohort of patients with peripartum cardiomyopathy (2022) (1)
Abstract 114: Safety And Efficacy Of CDR132L, A Novel Antisense Therapeutic Which Targets MicroRNA-132 In Heart Failure Patients (2021) (1)
Nothing but natural: targeting natural IgM in ischaemia/reperfusion injury. (2010) (1)
Right Ventricular Function Improves Early After Percutaneous Mitral Valve Repair in Patients Suffering From Severe Mitral Regurgitation (2022) (1)
[Large left ventricular aneurysm after silent myocardial infarction. Documentation by serial non-invasive imaging]. (2008) (1)
Imaging Inflammation in the Cardio-Renal Axis After Acute Myocardial Infarction (2020) (1)
Consequences of ventricular tachyarrhythmia in patients with a left ventricular assist device: Live recording in the ICU (2015) (1)
High rate of critical coronary stenosis in comatose patients with Non-ST-elevation out-of-hospital cardiac arrest (NSTE-OHCA) undergoing therapeutic hypothermia—Experience from the HAnnover COoling REgistry (HACORE) (2021) (1)
Intermittent accelerated idioventricular rhythm: a novel arrhythmia in lupus erythematosus (2016) (1)
The Value of an Immediate Invasive Strategy in Acute Coronary Syndrome: In Memoriam Henrick Joan Joost (Hein) Wellens (1935 to 2020). (2020) (1)
Onco-Cardiology: tackling the ugly (2020) (1)
Vitamin A Preserves Cardiac Energetic Gene Expression in a Murine Model of Diet-Induced Obesity. (2022) (1)
Computed-Tomography as First-line Diagnostic Procedure in Patients With Out-of-Hospital Cardiac Arrest (2022) (1)
Novel self‐expanding ALLEGRA transcatheter aortic valve for native aortic stenosis and degenerated bioprosthesis (2021) (1)
P2467Gut microbiota-dependent TMAO and risk of cardiovascular events in patients with stroke: relation to pro-inflammatory monocytes (2018) (1)
Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy (2022) (1)
Abstract 17166: Myeloid-specific Deletion of the Glucocorticoid Receptor Increases Mitochondrial Oxidative Stress and Impairs Wound Healing After Myocardial Infarction (2014) (1)
Early heightened inflammation promotes greater left ventricular remodeling following anterior myocardial infarction (2003) (1)
Response to blood pressure and sympathetic nervous system response to renal denervation. (2013) (1)
MORTALITY IN PATIENTS WITH OUT-OF-HOSPITAL CARDIAC ARREST UNDERGOING A STANDARDISED PROTOCOL INCLUDING THERAPEUTIC HYPOTHERMIA (2018) (1)
Inflammation and vascular remodeling in COVID-19 hearts (2022) (1)
Tu-P7: 153 Improvement of vascular dysfunction in diabetes by chronic guanylyl cyclase activation (2006) (1)
Poor oral health and coronary artery disease: Association or causality? (2018) (1)
activation and adhesion Novel role of the membrane-bound chemokine fractalkine in platelet (2010) (1)
Practical Patient Care Considerations with Use of Vericiguat After Worsening Heart Failure Events. (2022) (1)
584 Prevention of cardiac hypertrophy and failure in vivo by a novel microRNA antagonist (2008) (1)
Behavioral pathway to a broken heart: The link between adverse childhood experiences, depression, physical exercise and cardiovascular health (2022) (1)
Novel role for the membrane-bound chemokine fractalkine: A pathophysiologically relevant mechanism in platelet activation and adhesion (2003) (1)
[Oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation after coronary interventions]. (2019) (1)
Survey of clinical practice pattern in Germany’s certified chest pain units (2021) (1)
P6301Pro-inflammatory intermediate monocytes relate to right ventricular pressure in heart failure of adult congenital heart disease (2019) (1)
Heart failure 2.0 or 0.1? (2018) (1)
Innate Immunity in Heart Failure (2008) (1)
Leukocytoclastic vasculitis associated with endocarditis in a patient with transposition of the great arteries and mechanical valve replacement. (2017) (1)
Insulin and Insulin-Like Growth Factor 1 Signaling Preserves Sarcomere Integrity in the Adult Heart (2022) (1)
372 Transforming growth factor inhibition increases mortality and left ventricular dilatation after myocardial infarction (2007) (1)
Erratum to: ‘Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice’ (2016) (1)
Risk stratification in cardiogenic shock: from clinical utility to improving outcomes (2022) (1)
[Cardiovascular pharmacotherapy in the elderly : To avoid overtreatment and undertherapy]. (2018) (1)
Abstract 19496: Development of a Novel Model to Mimic Ischemic Microenvironments (2014) (1)
Posters (2009) (1)
Reduced vascular nitric oxide bioavailability in diabetes increases platelet activation in vivo: Rescue by endothelium-specific restoration of vascular NO production (2003) (1)
Depressive Symptoms and Quality of Life in Patients With Heart Failure and an Implantable Cardioverter-Defibrillator (2022) (1)
Abstract 247: The Endothelial Transcription Factor GATA2 Prevents the Development of Heart Failure During Pressure Overload Through Suppression of the Two Secreted Long Non-coding RNAs GADLOR1 and 2 (2017) (1)
Takotsubo cardiomyopathy - Everything's illuminated? (2015) (1)
Breastfeeding in Patients With Heart Failure (2019) (1)
Reply to 'More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy'. (2018) (1)
Regarding the article by Timmers et al. (2009) (1)
MicroRNA-146a regulates angiogenesis and functional regeneration after myocardial infarction (2020) (1)
Less-Invasive Left Ventricular Assist Device Implantations: Experience after More Than 100 Treated Patients (2016) (1)
The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies (2023) (1)
MiR-92a - a key player in cardiovascular remodeling (2014) (1)
[Vericiguat-new treatment option for patients with heart failure : Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA)]. (2020) (1)
Response to Letter Regarding Article, “Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension” (2009) (1)
Eisenmangel bei Herzinsuffizienz — neuer Diagnose-Therapie-Algorithmus, evidenzgeprüft und praktikabel (2018) (1)
Massive Schmerzen und livide Verfärbung des linken Beins nach intravaskulärer Heroininjektion bei einem 32-jährigen Patienten (2014) (1)
Positionspapier Nuklearkardiologie – Update 2018 * * Aktueller Stand der klinischen Anwendung (2018) (1)
Fokussiertes Update zur dualen Plättchenhemmung (2017) (1)
Implantation mechanischer Unterstützungssysteme und Herztransplantation bei Patienten mit terminaler Herzinsuffizienz (2022) (1)
Standardisierte Kontrastmittelsonographie (CEUS) in der klinischen Akut- und Notfallmedizin sowie Intensivmedizin (CEUS-Akut) (2022) (1)
Thrombozytenhemmung beim alten Menschen (2018) (1)
Medroxyprogesterone-acetate but not drospirenone ablates the protective function of 17b-estradiol against cardiovascular injury in aldosterone-treated rats (2006) (1)
Neue medikamentöse Therapieansätze bei chronischer Herzinsuffizienz (2017) (1)
Kardiogener Schock (2017) (1)
Ventrikuläre Herzrhythmusstörungen (2017) (1)
Expansion of CD14+HLA-DRneg/low monocytes and CD10neg neutrophils driving proinflammatory responses in patients with acute myocardial infarction (2020) (1)
Genetic reporter analysis reveals an expandable reservoir of OCT4+ cells in adult skin (2014) (1)
Schwangerschaftsassoziierte Kardiomyopathie (2015) (1)
Herzerkrankungen in der Schwangerschaft (2016) (1)
Großes linksventrikuläres Aneurysma nach stummem Myokardinfarkt (2008) (1)
Implantation mechanischer Unterstützungssysteme und Herztransplantation bei Patienten mit terminaler Herzinsuffizienz (2022) (1)
Positionspapier Herzinsuffizienz und Diabetes (2022) (1)
Update 2018 der ESC-Leitlinie zu kardiovaskulären Erkrankungen in der Schwangerschaft (2018) (1)
Kardiovaskuläre Pharmakotherapie im Alter (2018) (1)
Orale Antikoagulation und antithrombozytäre Therapie bei Patienten mit Vorhofflimmern nach Koronarintervention (2019) (1)
Abstract 19241: Downregulation of microRNA-494 Facilitates Smooth Muscle Cell Proliferation and Vascular Remodeling (2014) (0)
The No-Win Resuscitation: Ventricular Septal Rupture and Associated Acute Aortic Occlusion (2018) (0)
Adherence to the European Society of Cardiology guidelines on non-ST-segment elevation acute coronary syndrome (2021) (0)
Corrigendum to: A mouse model of cardiogenic shock. (2021) (0)
Cardiomyocyte Mineralocorticoid Receptor Function Post Myocardial (2011) (0)
433 Regression analysis of mortality data from the EPHESUS trial reveals significantly higher risk of death for patients with non‐ST segment elevation myocardial infarction (2008) (0)
Improvement of endothelial dysfunction by selective estrogen receptor - alpha dysfunction in ovarectomized sponteneously hypertensive rats. (2003) (0)
Separate origin of four major coronary arteries. (2020) (0)
Impact of fasting on stress systems and depressive symptoms in patients with major depressive disorder: a cross-sectional study (2022) (0)
[Erratum to: Standardized contrast-enhanced ultrasound (CEUS) in clinical acute and emergency medicine and critical care (CEUS Acute) : Consensus statement of DGIIN, DIVI, DGINA, DGAI, DGK, ÖGUM, SGUM and DEGUM]. (2022) (0)
Abstract 18607: High-Risk, Multi-Vessel Coronary Intervention Guided by Viability-Imaging and Supported by Awake-ECMO in Patients With Severe Ischemic Cardiomyopathy is Feasible, Safe, and Efficacious (2013) (0)
Coincidence of Spontaneous Coronary Artery Dissection With Apical Takotsubo Syndrome. (2022) (0)
Symptomkontrolle bei Herzinsuffizienzpatienten – was tun bei abfallender GFR und bei Hyperkaliämie? (2021) (0)
Angiopoietin-2 as a Biomarker for Heart Failure in Adults with Congenital Heart Disease (2013) (0)
Eisen und Digitalis bei Herzinsuffizienz (2021) (0)
PP.26.09: SPIKE RATE OF MULTI-UNIT MUSCLE SYMPATHETIC NERVE FIBERS FOLLOWING CATHETER-BASED RENAL NERVE ABLATION (2015) (0)
P4318Total atrial conduction time and left atrial strain highly predict occurrence of atrial fibrillation in patients with embolic stroke of unknown source (ESUS) during in-hospital stay (2017) (0)
N-Terminal Pro-B-Type Natriuretic Peptide Predicts Total and Cardiovascular Mortality in Individuals with or without Stable Coronary Artery Disease: The Ludwigshafen Risk and Cardiovascular Health Study Proteomics and Protein Markers (2007) (0)
Thrombo-embolic events in peripartum cardiomyopathy: results from the ESC EORP PPCM registry. (2023) (0)
Clinical practice guidelines of the ESC on myocardial revascularization, 2014 (2015) (0)
Cardiac amyloidosis—interdisciplinary approach to diagnosis and therapy (2022) (0)
Prognostic Value of NT-proBNP after Atrial Redirection Surgery (2015) (0)
Georg Ertl Enhanced Vascular Superoxide Production Endothelial Nitric Oxide Synthase and Soluble Guanylate Cyclase Expression : Role of Endothelial Dysfunction in Chronic Myocardial Infarction Despite Increased Vascular (1999) (0)
Lieferengpass Digitoxin (2022) (0)
Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy Introduction (2021) (0)
2371Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy based on the EURObservational registry on PPCM (2019) (0)
In Reply. (2017) (0)
P4915Vasorin regulates smooth muscle cell differentiation and neointima formation (2017) (0)
Effective Manuscripting about Patients with Congenital Cardiac Malformations (2023) (0)
Response to the Letter to the Editor by Kotsiou EHJ-CVP-D-19-00137. (2019) (0)
Late Breaking Abstract - Lung deflation with Indacaterol/Glycopyrronium improves cardiac function in COPD patients: The CLAIM Study (2017) (0)
[Uncommon tumor-associated deep vein thrombosis]. (2022) (0)
Letter by Hilfiker-Kleiner et al Regarding Article, "Modeling Peripartum Cardiomyopathy With Human Induced Pluripotent Stem Cells Reveals Distinctive Abnormal Function of Cardiomyocytes". (2019) (0)
Clinical Features and Outcomes of Patients With Malignancy (2020) (0)
Thromboembolic characteristics and role of anticoagulation in long-standing Fontan circulation (2022) (0)
[Aldosterone antagonists for all patients with heart failure?]. (2009) (0)
Konsensuspapier DGK, DGTHG (2022) (0)
IDH Mutations Are Associated with an Increased Risk of Coronary Artery Disease and Cardiotoxicity in Patients with Established AML (2020) (0)
P4143IL-6 production in the vascular adventitia and adventitia-media-crosstalk in neointima formation (2019) (0)
Thanks to Reviewers (2002) (0)
Malfunction of endothelial progenitor cells and endothelial function in patients with Fabry disease. (2007) (0)
[Notifications of the German Society for Internal Medicine]. (2008) (0)
Anti-androgenic therapy with finasteride in patients with chronic heart failure - a retrospective propensity score based analysis (2019) (0)
5761Relation of gut microbiota-dependent TMAO with aortic atherosclerosis: prognostic implication for patients with stroke (2017) (0)
Cardiovascular Mitochondria and Redox Control in Health and Disease Exercise training improves vascular mitochondrial function (2016) (0)
Abstract 17947: Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation (2015) (0)
Mineralocorticoid Receptor Antagonists in the Treatment of Coronary Artery Disease, Myocardial Infarction and Heart Failure (2019) (0)
der klinischen Anwendung (2018) (0)
Abstract 3111: Reverse Epidemiology in Chronic Heart Failure: Cumulative Predictive Power of Classical Cardiovascular Risk Factors (2008) (0)
Neue ESC-Leitlinien Herzinsuffizienz – Das Wichtigste zur Diagnose und Therapie an der Schnittstelle Kardiologie und Nephrologie (2022) (0)
Immune Checkpoint Inhibitor Associated Myocarditis and Cardiomyopathy: A Translational Review (2023) (0)
[Standardized contrast-enhanced ultrasound (CEUS) in clinical acute and emergency medicine as well as critical care (CEUS Acute) : Consensus statement of the DGIIN, DIVI, DGINA, DGAI, DGK, ÖGUM, SGUM und DEGUM]. (2022) (0)
Abstract 13413: Improved Healing by Immediate Selective Mineralocorticoid Receptor Antagonism After Experimental Myocardial Infarction: Modulation of Monocyte Subset Dynamics and MicroRNA Dysregulation (2012) (0)
P4661Routine computed tomography after out-of-hospital cardiac arrest (2018) (0)
Abstract 12608: Detrimental Role of Complement After Myocardial Infarction (2010) (0)
Aldosteronrezeptorblockade nach akutem Myokardinfarkt mit Herzinsuffizienz (2006) (0)
Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial. (2023) (0)
TCT-514 Bi-ventricular Mechanical Support: Predicting Success (2017) (0)
Non-Compaction-Kardiomyopathie (2015) (0)
SCORED and SOLOIST: the next scores for SGLT2 inhibitors. (2021) (0)
A practical approach to the guideline‐directed pharmacological treatment of heart failure with reduced ejection fraction (2022) (0)
Abstract 153: Inhibition of the 5-a-reductase Reduces Cardiac Hypertrophy and Improves Cardiac Function (2013) (0)
Prevalence of HSPB6 gene variants in peripartum cardiomyopathy: Data from the German PPCM registry. (2023) (0)
674 Prognostic value of androgens in male patients with chronic heart failure (2007) (0)
What are the effects of six month personalized endurance training on work ability in middle-aged sedentary women: A randomized controlled trial (2020) (0)
What needs to be known about longer-term management and prognosis? (2021) (0)
Blood vessel control of macrophage maturation promotes arteriogenesis in ischemia (2017) (0)
Abstract 18041: The Novel Mineralocorticoid Receptor Antagonist Finerenone Attenuates Neointima Formation After Vascular Injury (2016) (0)
Abstract 2041: Low P2Y12-Specific Platelet Inhibition in Clopidogrel-Treated Patients with Coronary Artery Disease is Common and not Reliably Detected by Conventional Aggregation Tests (2007) (0)
[Symptom control in heart failure patients - how to handle GFR decrease and hyperkalaemia]. (2021) (0)
Losing Track by Tracking Speckles (0)
Role of the renin-angiotensin-aldosterone system in diastolic dysfunction and heart failure 1 (2009) (0)
EFFICACY OF PRASUGREL GIVEN IMMEDIATELY AFTER PERCUTANEOUS CORONARY INTERVENTION IN ACUTE MYOCARDIAL INFARCTION (2015) (0)
Abstract 16716: Inhibition of Microrna-146a Enhances Angiogenesis and Functional Recovery After Myocardial Infarction and Hindlimb Ischemia (2013) (0)
Molecular Imaging of Chemokine Receptor CXCR4 Early After Myocardial Infarction Predicts Left Ventricular Remodeling (2020) (0)
Outcomes of patients with initial acute respiratory failure on veno-venous extracorporeal membrane oxygenation (ECMO) requiring additional circulatory support by VVA ECMO (2022) (0)
YI-807 ENHANCED SYSTEMIC NO BIOAVAILABILITY BY GROWTH-HORMONE MEDIATED IGF-1 INCREASE IMPROVES NUMBER AND FUNCTION OF ENDOTHELIAL PROGENITOR CELLS IN AGED INDIVIDUALS (2007) (0)
Abstract 12413: 5-Lipoxygenase Facilitates Healing after Myocardial Infarction (2011) (0)
Die Kardiologie (2023) (0)
Abstract 336: Cardiomyocyte-specific Deletion of the Mineralocorticoid Receptor attenuates Cardiac Dilatation and Dysfunction after Myocardial Infarction (2008) (0)
Leitlinien des European Resuscitation Council (ERC) zur kardiopulmonalen Reanimation 2021: Update und Kommentar (2022) (0)
Abstract 9884: Cardiac Iron Concentration in Relation to Systemic Iron Status and Disease Severity in Dilated Cardiomyopathy (2019) (0)
[From cardiovascular risk to chronic heart failure]. (2008) (0)
Abstract 5301: Fractalkine Desensitizes Platelets to Platelet Inhibition by the Endogenous Platelet Inhibitor Prostacyclin (2009) (0)
Abstract: 563 ROLE OF NNOS IN ATHEROSCLEROSIS (2009) (0)
Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. (2019) (0)
Induced by Angiotensin II Uncoupling and Nitro-oxidative Stress Endothelial Nitric-oxide Synthase Inflammatory Monocytes Determine (2014) (0)
[Iron deficiency in heart failure. A new diagnostic therapy algorithm - evidence-tested and workable]. (2018) (0)
[Pseudoaneuryma after transradial puncture in systemic lysis of basilar artery thrombosis]. (2016) (0)
Tu-P7:75 Chronic guanylyl cyclase activation reduces platelet activation in diabetic rats (2006) (0)
Secreted long non-coding RNAs Gadlor1 and Gadlor2 aggravate cardiac remodelling during pressure overload by affecting multiple cardiac cell types (2023) (0)
Neonatal mice adapt to pressure overload by inducing cardiomyocyte proliferation and angiogenesis (2018) (0)
Viability-guided, extracorporeal membrane oxygenation (ECMO) supported high-risk coronary intervention results in early clinical and functional benefit in severe ischemic cardiomyopathy - Results of a pilot project (2012) (0)
P4913Adventitial cytokine production is critical for negative vascular remodelling (2017) (0)
Herzbeteiligung beo COVID-19: Makrophagen-getriebene Entzündung und Gefäßneubildung (2023) (0)
Abstract 5390: The Endothelial Nitric Oxide Synthase Enhancer AVE9488 Increases Circulating Endothelial Progenitor Cells and Prevents Heart Failure Early after Myocardial Infarction (2008) (0)
Zusatztherapie für eine bessere Prognose : Wer profitiert von Aldosteronantagonisten? (2009) (0)
[Primary diagnosis of heart failure in ambulatory and hospitalized patients]. (2008) (0)
Abstract 254: Growth Hormone Treatment of Healthy Middle-aged Volunteers Improves Nitric Oxide Bioavailability and Circulating Endothelial Progenitor Cell Levels via Insulin-like Growth Factor-1 (2007) (0)
Abstract 19697: Left Ventricular Unloading by Impella(R) Microaxial Flow Pump for Treatment of Left Ventricular Overload in Venoarterial Ecmo Supported Cardiogenic Shock Patients (2012) (0)
MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart (2012) (0)
Inclusion of oral glucose tolerance testing for diabetes screening in patients with ST-elevation myocardial infarction. (2021) (0)
677 Inhibition of p38 MAP kinase improves endothelial dysfunction in chronic heart failure: role of vascular superoxide anion production (2003) (0)
Restoration of endothelial nitric oxide bioavailability in myocardial endothelial cells treated with dexamethasone (2012) (0)
Absence of NF- (cid:1) B subunit p50 improves heart failure after myocardial infarction (2006) (0)
Biventricular Mechanical Support Combining Impella Microaxial Pump and Veno-arterial ECLS Rescues High-Risk Patients in Refractory Cardiogenic Shock (2017) (0)
Giant pericardial effusion: drain it all? (2016) (0)
Abstract 14565: Multidrug Resistance Associated Protein-1 (MRP-1) Deficiency Diminishes Aging Induced Cardiovascular Dysfunction (2012) (0)
PO308 A Prolonged Corrected QT Interval Predicts Poor Outcome in Peripartum Cardiomyopathy (2018) (0)
Why and How You Get the Whole Country ’ s Healthcare Harnessed for Biomedical Science and Care (2013) (0)
Natriuretic Peptide Receptor 1, a Novel Player in Peripartum Heart Failure. (2020) (0)
Prävention des linksventrikulären Remodelings (2008) (0)
Multimodality cardiac imaging for diagnosing rare causes of cardiac arrest (2013) (0)
Vitamin A regulates tissue-specific organ remodeling in diet-induced obesity independent of mitochondrial function (2023) (0)
[Relative improvement of the quality of life (interview by Philip Gräzel)]. (2012) (0)
RNA-binding motif protein 38 inhibits re-endothelialization following vascular injury (2013) (0)
Corrigendum to "Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice" Journal of Molecular and Cellular Cardiology 122 (2018) 114-124. (2018) (0)
Eisenmangel bei Herzinsuffizienz-Patienten (2019) (0)
Abstract 4912: Multidrug Resistance Associated Protein-1 (MRP-1) Regulates Endothelial Cell Apoptosis (2009) (0)
Response to: Antithrombotic therapy for elderly patients with acute coronary syndrome: reasons to be cautious (2019) (0)
Skeletal muscle derived Musclin protects the heart during pathological overload (2022) (0)
Inhibition of microRNA-146a enhances angiogenesis and functional recovery after myocardial infarction (2013) (0)
Normal endothelial but altered arterial development in MAPK-activated protein kinase 2 deficient mice (2013) (0)
P1706Neurological outcome in patients with out-of-hospital cardiac arrest undergoing a standardised protocol including therapeutic hypothermia and routine coronary angiography (2019) (0)
Acute echocardiographic and electrocardiographic effects of triggered left ventricular pacing (2022) (0)
Abstract 714: Targeting Coagulation Factor XII to Protect from Cardiac Ischemia Reperfusion Injury (2007) (0)
Thanks to Reviewers (2016) (0)
6010Thromboembolic prevention in adolescents and adults with Fontan circulation: Is ASS a therapeutical option in long-standing Fontan circulation? (2018) (0)
P366A novel growth factor promotes endothelial recovery following vascular injury and prevents neointima formation (2018) (0)
Correction to: Nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM) (2022) (0)
P2734Parameters indicative for prognostic and neurologic outcome: insights from the Hannover Hypothermia Registry (2017) (0)
Pronóstico a largo plazo de los pacientes con síndrome de Takotsubo (2018) (0)
Treatment Options for Acute Heart Failure (2019) (0)
Inhibition of Sonic hedgehog signaling impedes perivascular stem cell signaling and prevents neointimal lesion formation (2013) (0)
Adventitial fibroblasts are key regulators of neointima formation (2017) (0)
Thanks to Reviewers (2006) (0)
Endothelial NO Synthase Target of Aldosterone Johann Bauersachs (2006) (0)
584 Diminished endothelial progenitor cell mobilisation from bone marrow after acute large myocardial infarction: Differential stimulation by ACE inhibition or statin treatment (2005) (0)
Abstract 206: A New MicroRNA Family Regulating Cardiac Autophagy and Hypertrophy (2012) (0)
405 The impact of the appetite stimulant megestrol acetate of survival, body weight and cardiac function in a rat model of chronic heart failure (2007) (0)
Abstract 1758: Attenuation of Angiotensin II induced Hypertension, Vascular Dysfunction and Cardiomyocyte Hypertrophy by Overexpression of Thioredoxin-2 (2008) (0)
We-W34:5 Fractalkine induces vascular dysfunction and reduces nitric oxide bioavailability by increased generation of superoxide anions (2006) (0)
Leukocyte tracking by simultaneous dual isotope cardiac CZT imaging: Accuracy in suspected endocarditis. (2015) (0)
Comorbidities and Co-Existing Conditions in Heart Failure Around Pregnancy (2019) (0)
Novel Strategies in AntiPlatelet Treatment for Coronary Artery Disease (2009) (0)
Oxidative Stress Early After Myocardial Infarction Mineralocorticoid Receptor Blockade Improves Vasomotor Dysfunction and Vascular (2007) (0)
Corrigendum to: Maintenance Immunosuppression Is Associated With Better Outcome in the 2017/2018 Influenza Epidemic (2020) (0)
Symmetrical Dimethylarginine Is a Better Biomarker for Systemic Ventricular Dysfunction in Adults after Atrial Repair for Transposition of the Great Arteries Than NT-proBNP (2013) (0)
437 A score based on echocardiographic parameters highly predicts atrial fibrillation (2020) (0)
Outcomes of patients with acute respiratory failure on veno-venous extracorporeal membrane oxygenation requiring additional circulatory support by veno-venoarterial extracorporeal membrane oxygenation (2022) (0)
Abstract 486: Targeting Bone Marrow Endothelial Nitric Oxide Synthase (eNOS) by the eNOS Enhancer AVE9488 Increases Circulating Endothelial Progenitor Cells After Myocardial Infarction (2006) (0)
Implantation mechanischer Unterstützungssysteme und Herztransplantation bei Patienten mit terminaler Herzinsuffizienz (2022) (0)
Digitalis in heart failure: declining use and ongoing outcome trials. (2023) (0)
Cardiomyopathies—past, present, future (2020) (0)
Th-W52:5 Age-dependent impairment of endothelial progenitor cells is corrected by growth hormone mediated increase of insulin-like growth factor-1 (2006) (0)
Mitteilungen der DGIM 09/2008 (2008) (0)
P401An unusual case of intramyocardial mass (2019) (0)
Insights into the multi-organ inflammatory response after acute myocardial infarction by clinical quantitative FDG PET-CT (2013) (0)
Efficacy of pharmacological and interventional treatment for resistant hypertension-a network meta-analysis (2023) (0)
Negative and reversible feedback inhibition of the endothelial nitric oxide (NO) synthesis by interleukin-1β (IL-1β)-induced generation of nitric oxide (1997) (0)
Retinal myeloid cells regulate tip cell selection and vascular branching morphogenesis via Notch ligand Delta-like 1 (2019) (0)
Circulating fibroblast activation protein α is reduced in acute ischemic stroke (2022) (0)
What can be learned from the global registry on PPCM? (2021) (0)
Ein neuartiges Studiendesign mit Magnetresonanz-Bildgebungsverfahren zur Untersuchung des Effekts der Indacaterol/Glycopyrronium Fixdosiskombination auf die kardiale Funktion bei COPD Patienten: die CLAIM-Studie (2016) (0)
Altered compositions of monocyte, T lymphocyte and NK cell subsets in heart failure of adult congenital heart disease (2022) (0)
C1q and Tumor Necrosis Factor Related Protein 9 Protects from Diabetic Cardiomyopathy by Alleviating Cardiac Insulin Resistance and Inflammation (2023) (0)
Indacaterol/Glycopyrronium verbessert pulmonale Perfusion und Ventilation bei überblähten COPD Patienten (2019) (0)
Mitteilungen der DGIM (2007) (0)
The challenge of defining best practice treatment for Takotsubo syndrome with shock. (2022) (0)
Cinefluoroscopy for assessment of mechanical heart valves with suspected dysfunction (2022) (0)
Secreted long non-coding RNAs Gadlor1 and Gadlor2 affect multiple cardiac cell types and aggravate cardiac remodeling during pressure overload (2022) (0)
P2779Left ventricular unloading with a microaxial flow-pump (2017) (0)
Abstract 3709: Fractalkine Modulates Recruitment Of Monocytic Cells Following Rupture Of Atherosclerotic Plaque (2008) (0)
Novel Therapeutic Concepts Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction : integrating evidence into clinical practice (2012) (0)
Stellungswechsel (2010) (0)
First-in-man Implantation of a Cardiac Microcurrent Device for Chronic Systolic Heart Failure. (2021) (0)
In Reply. (2021) (0)
Deep Learning für die automatische Bestimmung von klinisch relevanten Herzparametern mittels Kardio-MRT (2018) (0)
Adipositas und Herzinsuffizienz (2008) (0)
Abstract 873: Differential Effects of Long-Acting Nitrates on Endothelial Progenitor Cells are Determined by Reactive Oxygen Species Formation (2006) (0)
Versorgung von Herzinsuffizienzpatienten – eine interdisziplinäre Herausforderung (2021) (0)
Comparison of the American PPCM Registry Data With International Registries. (2016) (0)
Gemeinsamer Kommentar der Deutschen Gesellschaft für Kardiologie (DGK) und der Deutschen Gesellschaft für Thorax‑, Herz- und Gefäßchirurgie (DGTHG) zu den Leitlinien (2021) der ESC/EACTS zum Management von Herzklappenerkrankungen (2022) (0)
Corrigendum: Regulation of monocyte cell fate by blood vessels mediated by Notch signalling (2017) (0)
Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM) (2022) (0)
Grobes linksventrikuläres Aneurysma nach stummem Myokardinfarkt : Dokumentation mittels serieller nicht-invasiver Bildgebung (2008) (0)
Frühe Implementierung der „Fantastic four“ bei Herzinsuffizienz mit reduzierter Ejektionsfraktion (2022) (0)
Abstract 15407: Pentaerythrityl Tetranitrate Treatment Improves Left Ventricular Function and Reduces Mitochondrial Superoxide Anion-Production in Rats With Ischemic Heart Failure (2010) (0)
Right ventricular adaptation to isolated temporary left ventricular support for cardiogenic shock (2022) (0)
Thanks to Reviewers (2018) (0)
Acknowledgment to Reviewers (1998) (0)
Sodium-Glukose-Transporter 2-Hemmer bei Herzinsuffizienz mit erhaltener Auswurffraktion (2023) (0)
Vericiguat – neue Therapieoption für Patienten mit Herzinsuffizienz (2020) (0)
Pseudoaneurysma nach transradialer Punktion bei systemischer Lyse einer Basilaristhrombose (2016) (0)
Aktueller Stand der klinischen Anwendung (2018) (0)
Response to catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to- control hypertensive patients: prospective case series. (2013) (0)
Medikamentöse Therapie der Herzinsuffizienz (2017) (0)
Klug entscheiden (2020) (0)
Behandlung der Herzinsuffizienz (2016) (0)
Kardiovaskuläre Risikofaktoren bei Erwachsenen mit angeborenen Herzfehlern - erkannt aber nicht behandelt? Eine Analyse der Daten des Nationalen Registers für angeborene Herzfehler e.V. (NRAHF) (2015) (0)
Medikamentöse Therapieoptionen der akuten Herzinsuffizienz (2019) (0)
A Mouse model of cardiogenic shock. (2021) (0)
Abstract 3830: MicroRNA-21 Derepresses MAPkinase-Signaling and its Antagonism Prevents Cardiac Failure (2008) (0)
Die Defibrillatorweste (2016) (0)
Standardisierte Kontrastmittelsonografie (CEUS) in der klinischen Akut- und Notfallmedizin sowie Intensivmedizin (CEUS Akut): Konsensuspapier der DGIIN, DIVI, DGINA, DGAI, DGK, ÖGUM, SGUM und DEGUM (2022) (0)
Erratum zu: Standardisierte Kontrastmittelsonographie (CEUS) in der klinischen Akut- und Notfallmedizin sowie Intensivmedizin (CEUS Akut) (2022) (0)
Abstract 12848: Increased Fractalkine Levels Are Associated With Impaired Clopidogrel Responsiveness in Patients With Coronary Artery Disease by Activating a Signal Transduction Pathway Similar to P2y12 (2010) (0)
Kommentierungen zum Positionspapier der DGK (2020) (0)
Leitlinien des European Resuscitation Council (ERC) zur kardiopulmonalen Reanimation 2021: Update und Kommentar (2022) (0)
Therapie der Herzinsuffizienz mit reduzierter Ejektionsfraktion (2020) (0)
Kardiovaskuläre microRNAs-kleine Regulatoren machen grossen Eindruck (2009) (0)
Digitalis bei Herzinsuffizienz (2017) (0)
Abstract 413: Different Effects Of Organic Nitrates On Endothelial Progenitor Cell Mobilisation And Endothelial Function In Patients With Established Coronary Artery Disease (2008) (0)
Pseudoaneurysma nach transradialer Punktion bei systemischer Lyse einer Basilaristhrombose (2016) (0)
Lungenentblähung mit Indacaterol/Glycopyrronium verbessert die kardiale Funktion bei COPD Patienten: Die CLAIM Studie (2018) (0)
Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity (2018) (0)
Barorezeptoraktivierungstherapie bei Herzinsuffizienz mit reduzierter systolischer Funktion (2020) (0)
Inter- and Intracellular Mechanisms of Cardiac Remodeling, Hypertrophy and Dysfunction (2019) (0)
Gemeinsamer Kommentar der Deutschen Gesellschaft für Kardiologie (DGK) und der Deutschen Gesellschaft für Thorax‑, Herz- und Gefäßchirurgie (DGTHG) zu den Leitlinien (2021) der ESC/EACTS zum Management von Herzklappenerkrankungen (2022) (0)
Verwendung von cse-hemmern zur behandlung von herzinsuffizienz (2001) (0)
Peripartum cardiomyopathy – a global challenge (2022) (0)
Thromboembolic Prevention in Adolescents and Adults with Long-standing Fontan Circulation: Is ASA Equipotential to Anticoagulation? (2019) (0)
Herzinsuffizienz – Fortschritte in Diagnostik und Therapie (2021) (0)
Psychiatric morbidity in adults with congenital heart disease: Rare disease or frequent problem? (2014) (0)
P5691First series of Impella mechanical circulatory support for takotsubo syndrome with shock (2018) (0)
Empagliflozin impairs smooth muscle cell proliferation, accelerates endothelial regeneration, and prevents neointima formation by altered expression of the vasoactive peptide apelin (2020) (0)
20Adventitial interleukin-6 release is critical for neointima formation (2018) (0)
13Vasorin controls smooth muscle cell proliferation by regulating EGFR activation (2018) (0)
Correction: Corrigendum: Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction (2016) (0)
Standardisierte Kontrastmittelsonographie (CEUS) in der klinischen Akut- und Notfallmedizin sowie Intensivmedizin (CEUS-Akut) (2022) (0)
Eine nicht alltägliche tumorassoziierte Thrombose (2022) (0)
023FIRST RESULTS OF 111 MINIMALLY-INVASIVE LEFT VENTRICULAR ASSIST DEVICE IMPLANTATIONS AT A SINGLE-CENTRE (2014) (0)
Abstract 2963: Circulating Endothelial Progenitor Cells in Patients with Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension (2007) (0)
Role of the renin-angiotensin-aldosterone system in diastolic dysfunction and heart failure (2009) (0)
Gut microbiota-dependent TMAO, aortic atherosclerosis and risk of cardiovascular events in patients with stroke (2018) (0)
Abstract 195: TIP30 Interferes With Protein Synthesis And Inhibits Cardiac Hypertrophy (2013) (0)
Cardiac Fibroblast Activation in Patients After Acute Myocardial Infarction: Integration with Magnetic Resonance Tissue Characterization and Functional Outcome (2022) (0)
Small Interference RNA-Mediated Knockdown of eNOS in EPC (2007) (0)
[Implantation of mechanical circulatory support systems and heart transplantation in patients with end-stage heart failure : Consensus paper of the DGK, DGTHG]. (2022) (0)
The role of l-arginine/l-homoarginine/nitric oxide pathway for aortic distensibility and intima-media thickness in stroke patients (2017) (0)
miRNA-200b—A Potential Biomarker Identified in a Porcine Model of Cardiogenic Shock and Mechanical Unloading (2022) (0)
Postinfarction posterior ventricular septal rupture mimicking a biventricular free wall rupture with extracardiac left-to-right shunt (2015) (0)
We-P11:32 Uncoupled endothelial nitric oxide synthase in diabetic bone marrow-impact on endothelial progenitor cells (2006) (0)
Clinical characteristics and long-term outcomes in patients with peripartum cardiomyopathy (PPCM) receiving left ventricular assist devices (LVAD). (2022) (0)
Microalbuminuria screening in patients with ST-elevation myocardial infarction. (2022) (0)
Abstract 19313: MicroRNA-146a Augments Vascular Smooth Muscle Cell Proliferation and Neointima Formation (2014) (0)
[A practical approach to guideline-directed pharmacological treatment for heart failure with reduced ejection fraction]. (2022) (0)
Light at the end of the tunnel? (2022) (0)
Qualifikation, Kenntnisse, Aufgaben und Verantwortlichkeiten des Klinischen Perfusionisten Kardiotechnik (KPK) (2021) (0)
Abstract 17103: VEGF-Mimicking Nanostructures for Ischemic Tissue Repair (2011) (0)
Vom kardiovaskulären Risiko zum chronischen Herzversagen (2008) (0)
Transcriptional control and RNA species-Vascular 307 MicroRNA-34 a role in vascular calcification (2016) (0)
Diverging Trends in Age at First Myocardial Infarction: Evidence from Two German Population-Based Studies (2020) (0)
Letters to the Editor (2009) (0)
261Decisive role of microRNA-494 in smooth muscle cell proliferation and vascular remodeling (2019) (0)
EKG-Quiz (2012) (0)
[Severe pain and livid discoloration in the left leg of a 32-year-old patient after intravascular heroin injection]. (2014) (0)
Recent patents on stem cell transplantation in cardiovascular medicine. (2007) (0)
Abstract 13806: Multidrug Resistance Associated Protein-1 (MRP-1) Deficiency Prevents Endothelial Dysfunction In Diabetes (2010) (0)
Abstract 17132: Inhibition of Sonic Hedgehog Signaling Attenuates Proliferation of Vascular Cells and Prevents Neointimal Lesion Formation (2013) (0)
Characterization of inflamed, acutely infarcted myocardial tissue by combined clinical FDG PET and CMR (2013) (0)
Aldosterone mediated dysfunction of human endothelial progenitor cells - Mechanisms and therapeutic opportunities. (2007) (0)
[Pseudoaneurysm after transradial puncture in systemic lysis of basilar artery thrombosis]. (2016) (0)
Abstract 5141: Guanylyl Cyclase Activation Using HMR1766 Improves Endothelial Function and Reduces Platelet Activation in Congestive Heart Failure (2009) (0)
P2800 Additive improvement of left-ventricular remodelling by selective aldosterone receptor blockade and at1 angiotensin II receptor antagonism in rat heart failure (2003) (0)
Empagliflozin prevents neointima formation by impairing smooth muscle cell proliferation and accelerating endothelial regeneration (2022) (0)
Impact of COVID-19 on Medical Supply in Adults With Congenital Heart Disease (2022) (0)
Saturday, 17 July 2010 (2010) (0)
Subcutaneous Emphysema Guided Diagnosis in Extensive Multilocal - Localizing the Air Vents: Functional Imaging (2013) (0)
Von Willebrand’s Factor as Long-Term Prognostic Factor in Adult Congenital Heart Disease (2020) (0)
Thanks to reviewers (2014) (0)
NO for the pregnant mother: no hypertension for the daughter? (2015) (0)
Aktivierung endogener antioxidativer Mechanismen durch Pentaerithrityltetranitrat (PETN) - Experimentelle und klinische Befunde (2009) (0)
Author response: Expansion of CD10neg neutrophils and CD14+HLA-DRneg/low monocytes driving proinflammatory responses in patients with acute myocardial infarction (2021) (0)
Peripartum Cardiomyopathy is Missing. (2022) (0)
Abstract 13824: Impact of the Transcription Factor GATA2 in Endothelial Cells on the Development of Heart Failure Through the Regulation of Two Secreted Long Non-Coding RNAs (2014) (0)
Abstract 3307: Tissue Specific Effects of the Transcription Factor Nuclear Factor Kappa B on Myocardial Ischemic Injury (2009) (0)
Abstract 11441: Musclin, a Novel Skeletal Muscle Derived Myokine, Attenuates LV Dysfunction and Myocardial Fibrosis During Cardiac Cachexia (2018) (0)

This paper list is powered by the following services:

Other Resources About Johann Bauersachs

en.wikipedia.org

What Schools Are Affiliated With Johann Bauersachs?

Johann Bauersachs is affiliated with the following schools:

Johann Bauersachs's Academic­Influence.com Rankings